showed that a prostate cancer risk SNP rs11672691 (resides in the promoter of a short isoform of long noncoding RNA PCAT19 (PCAT19‐short) and the third intron of the long isoform (PCAT19‐long)) is associated with decreased and up‐regulated expression levels of PCAT19‐short and PCAT19‐long, respectively.[89] Hua et al. This evidence concerns the gene PCAT19 and prostate carcinoma.